Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06731426 · ClinicalTrials.gov registry record · NA
Multi-session, Personalized Cognitive Bias Modification for Thought-Action-Fusion
A NA study of OCD, sponsored by Han Joo Lee.
- Recruiting
- Registry status
- NA
- Development phase
- 84
- Enrollment target
- 1
- Study location
NCT06731426 is a NA study of OCD that is actively recruiting participants, run by Han Joo Lee. The registered enrollment target is 84 participants, below the 813-participant average among 18 other OCD trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06731426, a NA study of OCD, is actively recruiting participants, sponsored by Han Joo Lee.
- RECRUITING
- Registry status
- NA
- Development phase
- 84 participants
- Enrollment target
- 1
- Study location
Study Summary
Thought-Action-Fusion (TAF) is a cognitive bias that posits (1) having unwanted thoughts is morally equivalent to acting upon the thoughts (TAF-Moral; e.g., "Thinking about harming a child is as immoral as actually harming a child") and (2) having unwanted thoughts will increase the likelihood of the thoughts happening in real life (TAF-Likelihood; e.g., "My mother will get into a car accident, because I thought about it"). Given its central role in the development and maintenance of OCD, TAF has emerged as a potential treatment target for obsessive-compulsive disorder (OCD). Previous research has demonstrated that TAF is indeed a malleable construct. This study aims to examine the effects of a multi-session, personalized cognitive bias modification (CBM) for thought-action-fusion (TAF) on improving obsessive-compulsive (OC) symptoms in a college sample.
Conditions Studied
Interventions
- BEHAVIORAL CBM-TAF
- BEHAVIORAL CBM-SMP
Study Locations (1)
Wisconsin
- UWM Anxiety Disorders Laboratory - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2024-04-18 |
| Est. Completion | 2026-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06731426
The ClinicalTrials.gov registry entry for NCT06731426 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 813-participant average among 18 other OCD trials with a reported enrollment target (90% lower). The listed sponsor is Han Joo Lee, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with OCD appearing as the primary indexed condition, and to 2 interventions - of which CBM-TAF is the first listed.
NCT06731426 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.
Frequently Asked Questions
What is clinical trial NCT06731426 about?
NCT06731426 is a clinical study titled "Multi-session, Personalized Cognitive Bias Modification for Thought-Action-Fusion". Thought-Action-Fusion (TAF) is a cognitive bias that posits (1) having unwanted thoughts is morally equivalent to acting upon the thoughts (TAF-Moral; e.g., "Thinking about harming a child is as immoral as actually harming a child") and (2) having unwanted thoughts will increase the likelihood of th...
What is the current status of trial NCT06731426?
This trial is currently recruiting. It is a NA study. The enrollment target is 84 participants. The study started on 2024-04-18. Estimated completion is 2026-05-31.
What conditions does trial NCT06731426 study?
This clinical trial studies the following conditions: OCD.
What interventions are being tested in trial NCT06731426?
The interventions under investigation include: CBM-TAF (BEHAVIORAL), CBM-SMP (BEHAVIORAL).
Who is sponsoring clinical trial NCT06731426?
This trial is sponsored by Han Joo Lee, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06731426 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for OCD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Neuromodulation for a Novel OCD Biomarker and Treatment
RECRUITING · NA
-
Personalized DBS for OCD Guided by Stereoencephalography Mapping
RECRUITING · NA
-
Neurostimulation Versus Therapy for Problems With Emotions
RECRUITING · NA
-
How Hormones and Exposure and Response Prevention (EX/RP) Affect the Brain of People With OCD
RECRUITING · NA
-
Implementing Team-Based Treatment for Pediatric Anxiety in Community Mental Health Settings
RECRUITING · NA
-
Accelerated TMS for Depression and OCD
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.